I
INmune Bio D
D
INMB
6.38500
USD
-0.87
(-11.93%)
مغلق
حجم التداول
64,036
الربح لكل سهم
-2
العائد الربحي
-
P/E
-3
حجم السوق
148,198,257
الأخبار المقالات
العنوان: INmune Bio
القطاع: Healthcare
الصناعة: Biotechnology
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.